TrialBritish journal of cancer2023

Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.

Makoto Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.